CN102512656B - 盐酸喹那普利药物组合物 - Google Patents
盐酸喹那普利药物组合物 Download PDFInfo
- Publication number
- CN102512656B CN102512656B CN201110444527XA CN201110444527A CN102512656B CN 102512656 B CN102512656 B CN 102512656B CN 201110444527X A CN201110444527X A CN 201110444527XA CN 201110444527 A CN201110444527 A CN 201110444527A CN 102512656 B CN102512656 B CN 102512656B
- Authority
- CN
- China
- Prior art keywords
- quinapril hydrochloride
- pharmaceutical composition
- lactose
- quinapril
- pregelatinized starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110444527XA CN102512656B (zh) | 2011-12-27 | 2011-12-27 | 盐酸喹那普利药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110444527XA CN102512656B (zh) | 2011-12-27 | 2011-12-27 | 盐酸喹那普利药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102512656A CN102512656A (zh) | 2012-06-27 |
CN102512656B true CN102512656B (zh) | 2013-11-27 |
Family
ID=46283908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110444527XA Active CN102512656B (zh) | 2011-12-27 | 2011-12-27 | 盐酸喹那普利药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102512656B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116981446A (zh) * | 2021-03-03 | 2023-10-31 | 苏州盛迪亚生物医药有限公司 | 一种包含吡啶并嘧啶类衍生物的药物组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3727848B2 (ja) * | 1998-06-05 | 2005-12-21 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 酸化マグネシウムを使用する、ace阻害剤を含有する組成物の安定化 |
CN1618426A (zh) * | 2003-11-21 | 2005-05-25 | 上海旭东海普药业有限公司 | 一种含有卡托普利的药物组合物及其制备方法 |
-
2011
- 2011-12-27 CN CN201110444527XA patent/CN102512656B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102512656A (zh) | 2012-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10016408B2 (en) | Chemokine CXCR4 receptor modulators and uses related thereto | |
TWI731354B (zh) | (2R,5S,13aR)-7,9-二側氧基-10-((2,4,6-三氟苄基)胺甲醯基)-2,3,4,5,7,9,13,13a-八氫-2,5-甲橋吡啶並[1’,2’:4,5]吡𠯤並[2,1-b][1,3]氧氮呯-8-醇化鈉 | |
WO2016145910A1 (zh) | Nadh和nmn在制备帕金森病药物或保健品的应用 | |
CN102579440B (zh) | 一种稳定的左旋氨氯地平组合物 | |
WO2017011517A1 (en) | Bis-amines, compositions, and uses related to cxcr4 inhibition | |
CN102008449B (zh) | 一种兰索拉唑肠溶微丸及其制备方法 | |
CN102512656B (zh) | 盐酸喹那普利药物组合物 | |
CN103690960A (zh) | 甲磺酸洛美他派药物组合物及制备方法 | |
CN102349902A (zh) | 一种含有左旋氨氯地平和坎地沙坦酯的全新药物组合物及其制备方法 | |
MX2012011415A (es) | Terapia de combinacion que comprende un antagonista de ccr5, un inhibidor de proteasa de vih-1, y un potenciador farmacocinetico. | |
EP3143005B1 (en) | Chemokine cxcr4 and ccr5 receptor modulators and used related thereto | |
AU2011270133B2 (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction | |
CN106491546B (zh) | 一种苯磺酸氨氯地平片的制备方法 | |
CN102342942A (zh) | 一种全新口服固体药用组合物及其制备方法 | |
CN104490881A (zh) | 一种含有盐酸马尼地平和阿齐沙坦的片剂及其制备方法 | |
CN103127028A (zh) | 一种含有富马酸替诺福韦二吡呋酯的胶囊剂 | |
CN105832731A (zh) | 一种治疗高血压的药物及其制备方法 | |
LU500100B1 (en) | Antihypertensive pharmaceutical composition, and preparation method and use thereof | |
CN107998095A (zh) | 一种度鲁特韦薄膜包衣片制剂及其制备方法 | |
CN101972254B (zh) | 一种左旋氨氯地平或其可药用盐固体制剂及其制备方法 | |
EP3429588A1 (en) | Amide-sulfamide derivatives, compositions, and uses related to cxcr4 inhibition | |
CN107550895A (zh) | 一种盐酸精氨酸制剂 | |
CN106539807B (zh) | 一种稳定的药物组合物及其制备方法 | |
CN116354831A (zh) | 薏苡仁中具有降尿酸功能化合物1-苯基-1,3,3-丙三胺的分离与应用 | |
CN106692148A (zh) | 一种卡利拉嗪药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YANG XIAOMAN Free format text: FORMER OWNER: TIANJIN SONGRUI MEDICAL TECHNOLOGY CO.,LTD. Effective date: 20140319 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300250 HEDONG, TIANJIN TO: 300250 HEBEI, TIANJIN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140319 Address after: 300250 Taixing apartment, Taixing Road, Tianjin, 14-1-102 Patentee after: Yang Xiaoman Address before: 300250 Taixing apartment, Taixing Road, Hedong District, Tianjin, 14-1-102 Patentee before: Tianjin Songrui Medical Technology Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: NANJING HAILING CHINESE MEDICINE PHARMACEUTICAL TE Free format text: FORMER OWNER: YANG XIAOMAN Effective date: 20141016 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Hao Inventor after: Sun Jingshun Inventor after: Ding Fei Inventor after: Hu Zhengfang Inventor before: Zhang Hao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300250 HEBEI, TIANJIN TO: 210049 NANJING, JIANGSU PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHANG HAO TO: ZHANG HAO SUN JINGSHUN DING FEI HU ZHENGFANG |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141016 Address after: No. 9 Qixia Xianlin Avenue District of Nanjing City, Jiangsu province 210049 Patentee after: Nanjing Hailing Chinese Medicine Pharmaceutical Technology Research Co., Ltd. Address before: 300250 Taixing apartment, Taixing Road, Tianjin, 14-1-102 Patentee before: Yang Xiaoman |